Thrombolytic Medicine

Thrombolytic Medicine
Eminase Thrombolytic medicine is a group of drugs used to break up or dissolve blood clots. Blood clots are the main cause of stroke and heart attack, making these drugs vital in the modern era where cardiovascular diseases are the leading cause of death. Eminase is among the most utilized of these drugs. The medicine is given through vein injection following heart attack symptoms, which aims to prevent blood from clotting.
Eminase is a purified and complex human plasminogen and bacterial streptokinase acylated to protect the enzyme's active site. Once administered, the acyl hydrolyzation of the acyl group occurs (Khasa, 2017). As a result, the freezing activator complex is released. The process converts plasminogen to plasmin which works to degrade fibrin to fibrin products, preventing blood clotting. Since blood clotting is inhibited, bleeding is the most apparent side effect. However, others include irregular heart rhythm, fever, and low blood pressure. Rare side effects are skin rash, trouble breathing, bruising, cholesterol embolism, and blockage of blood vessels in the br...